morphine

Indications retained by WHO

Opioids or related analgesics and agents affecting opioid receptors; Pain.

Listed forms and strengths

• Parenteral > General injections > IV: 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 1 mg in 1 mL ampoule (morphine hydrochloride or morphine sulfate)
• Oral > Liquid: 10 mg per 5 mL (morphine hydrochloride or morphine sulfate); 5 mg per 5 mL (morphine hydrochloride or morphine sulfate)
• Parenteral > General injections > unspecified: 1 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate)
• Oral > Solid > tablet: 10 mg immediate release (morphine sulfate)
• Oral > Solid > dosage form: 10 mg slow-release (morphine hydrochloride or morphine sulfate); 200 mg slow-release (morphine hydrochloride or morphine sulfate); 100 mg slow-release (morphine hydrochloride or morphine sulfate); 60 mg slow-release (morphine hydrochloride or morphine sulfate); 30 mg slow-release (morphine hydrochloride or morphine sulfate); 5 mg slow-release (morphine hydrochloride or morphine sulfate)
• Oral > Solid > granules: 20 mg (morphine sulfate); 30 mg (morphine sulfate); 60 mg (morphine sulfate); 100 mg (morphine sulfate); 200 mg (morphine sulfate)

Forms retained in the model list; presentations available in each country may differ.